Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

NEWS From the American Heart Association

NEWS From the American Heart Association From, the American Heart Association sicians to enter careers in investigative science. Genentech to Fund 12 The awards typically provide support for two to Clinician-Scientists three years of research training and a subse- Genentech, Inc., a California-based biotech- quent period of independent research. nology company and founding member of the The next application deadline for AHA American Heart Association's Pharmaceutical Clinician-Scientist Awards is June 1, 1990. Roundtable, will provide $3 million to fund 12 More information may be obtained by writing Clinician-Scientist Awards in thrombolysis. the American Heart Association, Division of "Thrombolytic therapy has become an exam- Research Administration, 7320 Greenville ple of biotechnology benefiting human health," Avenue, Dallas, TX 75231, or calling 214- said Dr. David J. Martin Jr., Genentech's 706-1453. senior vice president of research and develop- ment. "Thrombolysis saves lives. We are proud Educational Materials to assist the American Heart Association in funding research in this important and exciting Educational materials for the public and the field of medical science." health professional are available from the According to Dr. James T. Willerson, chair- American Heart Association's National Cen- man of the AHA's Research Committee, "The ter. New materials for the public include: grant will allow new http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arteriosclerosis Wolters Kluwer Health

NEWS From the American Heart Association

Arteriosclerosis , Volume 10 (1) – Jan 1, 1990
Download PDF
8 pages

Loading next page...
 
/lp/wolters-kluwer-health/news-from-the-american-heart-association-iU0k7HwiDQ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
© 1990 by American Heart Association, Inc.
ISSN
0276-5047

Abstract

From, the American Heart Association sicians to enter careers in investigative science. Genentech to Fund 12 The awards typically provide support for two to Clinician-Scientists three years of research training and a subse- Genentech, Inc., a California-based biotech- quent period of independent research. nology company and founding member of the The next application deadline for AHA American Heart Association's Pharmaceutical Clinician-Scientist Awards is June 1, 1990. Roundtable, will provide $3 million to fund 12 More information may be obtained by writing Clinician-Scientist Awards in thrombolysis. the American Heart Association, Division of "Thrombolytic therapy has become an exam- Research Administration, 7320 Greenville ple of biotechnology benefiting human health," Avenue, Dallas, TX 75231, or calling 214- said Dr. David J. Martin Jr., Genentech's 706-1453. senior vice president of research and develop- ment. "Thrombolysis saves lives. We are proud Educational Materials to assist the American Heart Association in funding research in this important and exciting Educational materials for the public and the field of medical science." health professional are available from the According to Dr. James T. Willerson, chair- American Heart Association's National Cen- man of the AHA's Research Committee, "The ter. New materials for the public include: grant will allow new

Journal

Arteriosclerosis – Wolters Kluwer Health

Published: Jan 1, 1990

There are no references for this article.